Miransertib is an AKT inhibitor that is available via clinical trial for people with PROS.
Cloves Syndrome CommunitySupport. Research. Education.
Cloves Syndrome CommunityMiransertib is an AKT inhibitor that is available via clinical trial for people with PROS.